Key facts
- This page summarizes Sandra R. Hernandez MD's Form 4 filing for 23andMe Holding Co. (MEHCQ).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 28 Aug 2024, 16:27.
Sandra R. Hernandez MD - 26 Aug 2024 Form 4 Insider Report for 23andMe Holding Co. (MEHCQ)
- Reporting relationship
- Director
- Issuer ticker
- MEHCQ
- Reported as of
- 26 Aug 2024
- Net transaction value
- +$50,000
- SEC form
- 4
- Accepted by SEC
- 28 Aug 2024, 16:27:55 UTC
- Prior SEC filing
- 02 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sandra Hernandez, by Guy Chayoun, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Sandra R. Hernandez MD filed Form 4 for 23andMe Holding Co. (MEHCQ) on 28 Aug 2024.
Change
- Previous filing in this sequence was filed on 02 Jul 2024.
- Current net transaction value: +$50,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ME
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +658,485
- Change %
- +167%
- Price
- $0.000000
- Shares after
- 1,053,549
- Date
- 26 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
ME
transaction
Class A Common Stock
Award
- Transaction value
- $50,000
- Shares
- +149,655
- Change %
- +14%
- Price
- $0.3341
- Shares after
- 1,203,204
- Date
- 26 Aug 2024
- Ownership
- Direct
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Restricted stock units ("RSUs") issued pursuant to the 23andMe Holding Co. Amended and Restated Outside Director Compensation Policy effective as of September 6, 2023 (the "Director Compensation Policy"), all of which vest on the earlier of (a) the first anniversary of the grant date and (b) the date of the issuer's 2025 annual meeting of stockholders. Each RSU represents the contingent right to receive one share of Class A common stock of the issuer. The reporting person has elected to defer receipt of these shares until the end of service on the board of directors of the issuer pursuant to the 23andMe Holding Co. RSU Conversion and Deferral Program For Directors as amended and restated on September 6, 2023 (the "Conversion and Deferral Program").
Footnote F2
RSUs issued to the reporting person in lieu of cash retainer fees, at the election of the reporting person (the "RSU Election"), pursuant to the Director Compensation Policy and the Conversion and Deferral Program. Each RSU represents the contingent right to receive one share of Class A common stock of the issuer and is fully vested. The reporting person has elected to defer receipt of these shares until the end of service on the board of directors of the issuer pursuant to the Conversion and Deferral Program.
Footnote F3
Under the the Conversion and Deferral Program, the number of shares issued in lieu of cash retainer fees is determined by dividing the dollar amount of the cash retainer fees subject to the RSU Election by the closing price of a share of Class A common stock of the issuer on the Nasdaq Capital Market on the date of issuance, with any fractional share rounded down to the nearest whole share.